Πέμπτη 17 Αυγούστου 2017

FDA Approves Nivolumab for Some Metastatic Colorectal Cancers

FDA has granted accelerated approval to the immunotherapy drug nivolumab (Opdivo®) for patients with metastatic colorectal cancer whose tumors have alterations that affect DNA repair.



http://ift.tt/2vHvzpp

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου